Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Elisabeth van Wering
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Living Beings
Procedures
Physiology
Chemicals & Drugs
Phenomena
Anatomy
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
54
Pieters, Rob
45
van Dongen, Jacques
43
Veerman, Anjo
33
van der Does-van den Berg, Anna
33
Hählen, Karel
28
Kaspers, G J L
24
Beverloo, Berna
17
den Boer, Monique
16
Kamps, Willem
16
Szczepanski, Tomasz
15
van der Velden, V H J
15
Meijerink, Jules
14
Janka-Schaub, Gritta
10
Beishuizen, Auke
10
van Zantwijk, Christina
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Elisabeth van Wering (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Veerman Anjo J; Kamps Willem A; van den Berg Henk; van den Berg Eva; Bökkerink Jos P M; Bruin Marrie C A; van den Heuvel-Eibrink Marry M; Korbijn Carin M; Korthof Elisabeth T; van der Pal Karin; Stijnen Theo; van Weel Sipman Margreet H; van Weerden J Fransje; van Wering Elisabeth R; van der Does-van den Berg Anna;
Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).
The lancet oncology 2009;10(10):957-66.
-
2008: van Grotel Martine; van den Heuvel-Eibrink Marry M; van Wering Elisabeth R; van Noesel Max M; Kamps Willem A; Veerman Anjo J P; Pieters Rob; Meijerink Jules P P
CD34 expression is associated with poor survival in pediatric T-cell acute lymphoblastic leukemia.
Pediatric blood & cancer 2008;51(6):737-40.
-
2008: Appel I M; Kazemier K M; Boos J; Lanvers C; Huijmans J; Veerman A J P; van Wering E; den Boer M L; Pieters R
Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(9):1665-79.
-
2008: de Vries A C H; Langerak A W; Verhaaf B; Niemeyer C M; Stary J; Schmiegelow K; van Wering E R; Zwaan C M; Beishuizen A; Pieters R; van den Heuvel-Eibrink M M
T-cell receptor Vbeta CDR3 oligoclonality frequently occurs in childhood refractory cytopenia (MDS-RC) and severe aplastic anemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(6):1170-4.
-
2008: Van Vlierberghe Pieter; van Grotel Martine; Tchinda Joëlle; Lee Charles; Beverloo H Berna; van der Spek Peter J; Stubbs Andrew; Cools Jan; Nagata Kyosuke; Fornerod Maarten; Buijs-Gladdines Jessica; Horstmann Martin; van Wering Elisabeth R; Soulier Jean; Pieters Rob; Meijerink Jules P P
The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia.
Blood 2008;111(9):4668-80.
-
2008: Van Vlierberghe P; Homminga I; Zuurbier L; Gladdines-Buijs J; van Wering E R; Horstmann M; Beverloo H B; Pieters R; Meijerink J P P
Cooperative genetic defects in TLX3 rearranged pediatric T-ALL.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(4):762-70.
-
2008: Balgobind Brian V; Van Vlierberghe Pieter; van den Ouweland Ans M W; Beverloo H Berna; Terlouw-Kromosoeto Joan N R; van Wering Elisabeth R; Reinhardt Dirk; Horstmann Martin; Kaspers Gertjan J L; Pieters Rob; Zwaan C Michel; Van den Heuvel-Eibrink Marry M; Meijerink Jules P P
Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis.
Blood 2008;111(8):4322-8.
-
2008: van Grotel M; Meijerink J P P; van Wering E R; Langerak A W; Beverloo H B; Buijs-Gladdines J G C A M; Burger N B; Passier M; van Lieshout E M; Kamps W A; Veerman A J P; van Noesel M M; Pieters R
Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(1):124-31.
-
2007: de Vries Andrica C H; Stam Ronald W; Schneider Pauline; Niemeyer Charlotte M; van Wering Elisabeth R; Haas Oskar A; Kratz Christian P; den Boer Monique L; Pieters Rob; van den Heuvel-Eibrink Marry M
Role of mutation independent constitutive activation of FLT3 in juvenile myelomonocytic leukemia.
Haematologica 2007;92(11):1557-60.
-
2006: Van Vlierberghe Pieter; van Grotel Martine; Beverloo H Berna; Lee Charles; Helgason Tryggvi; Buijs-Gladdines Jessica; Passier Monique; van Wering Elisabeth R; Veerman Anjo J P; Kamps Willem A; Meijerink Jules P P; Pieters Rob
The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia.
Blood 2006;108(10):3520-9.
-
2006: van Grotel Martine; Meijerink Jules P P; Beverloo H Berna; Langerak Anton W; Buys-Gladdines Jessica G C A M; Schneider Pauline; Poulsen Tim S; den Boer Monique L; Horstmann Martin; Kamps Willem A; Veerman Anjo J P; van Wering Elisabeth R; van Noesel Max M; Pieters Rob
The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols.
Haematologica 2006;91(9):1212-21.
-
2006: Meier M; den Boer M L; Meijerink J P P; Broekhuis M J C; Passier M M C J; van Wering E R; Janka-Schaub G E; Pieters R
Differential expression of p73 isoforms in relation to drug resistance in childhood T-lineage acute lymphoblastic leukaemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(8):1377-84.
-
2006: von Bergh Anne R M; van Drunen Ellen; van Wering Elisabeth R; van Zutven Laura J C M; Hainmann Ina; Lönnerholm Gudmar; Meijerink Jules P; Pieters Rob; Beverloo H Berna
High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9.
Genes, chromosomes & cancer 2006;45(8):731-9.
-
2006: van Vlierberghe P; Meijerink J P P; Lee C; Ferrando A A; Look A T; van Wering E R; Beverloo H B; Aster J C; Pieters R
A new recurrent 9q34 duplication in pediatric T-cell acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(7):1245-53.
-
2006: te Loo D Maroeska W M; Kamps Willem A; van der Does-van den Berg Anna; van Wering Elisabeth R; de Graaf Siebold S N
Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(15):2332-6.
-
2006: van der Velden Vincent H J; de Bie Maaike; van Wering Elisabeth R; van Dongen Jacques J M
Immunoglobulin light chain gene rearrangements in precursor-B-acute lymphoblastic leukemia: characteristics and applicability for the detection of minimal residual disease.
Haematologica 2006;91(5):679-82.
-
2006: Brouwer Connie; Vermunt-de Koning Diana G M; Trueworthy Robert C; Ter Riet Patricia G J H; Duley John A; Trijbels Frans J M; Hoogerbrugge Peter M; Bökkerink Jos P M; van Wering Elisabeth R; De Abreu Ronney A
Monitoring of inosine monophosphate dehydrogenase activity in mononuclear cells of children with acute lymphoblastic leukemia: enzymological and clinical aspects.
Pediatric blood & cancer 2006;46(4):434-8.
-
2006: Stams W A G; Beverloo H B; den Boer M L; de Menezes R X; Stigter R L; van Drunen E; Ramakers-van-Woerden N L; Loonen A H; van Wering E R; Janka-Schaub G E; Pieters R
Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(3):410-6.
-
2006: Bourquin Jean-Pierre; Subramanian Aravind; Langebrake Claudia; Reinhardt Dirk; Bernard Olivier; Ballerini Paola; Baruchel André; Cavé Hélène; Dastugue Nicole; Hasle Henrik; Kaspers Gertjan L; Lessard Michel; Michaux Lucienne; Vyas Paresh; van Wering Elisabeth; Zwaan Christian M; Golub Todd R; Orkin Stuart H
Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(9):3339-44.
-
2005: Hubeek I; Stam R W; Peters G J; Broekhuizen R; Meijerink J P P; van Wering E R; Gibson B E S; Creutzig U; Zwaan C M; Cloos J; Kuik D J; Pieters R; Kaspers G J L
The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia.
British journal of cancer 2005;93(12):1388-94.
-
2005: Stams Wendy A G; den Boer Monique L; Beverloo H Berna; Kazemier Karin M; van Wering Elisabeth R; Janka-Schaub Gritta E; Pieters Rob
Effect of the histone deacetylase inhibitor depsipeptide on B-cell differentiation in both TEL-AML1-positive and negative childhood acute lymphoblastic leukemia.
Haematologica 2005;90(12):1697-9.
-
2005: Van Vlierberghe Pieter; Meijerink Jules P P; Stam Ronald W; van der Smissen Wendy; van Wering Elisabeth R; Beverloo H Berna; Pieters Rob
Activating FLT3 mutations in CD4+/CD8- pediatric T-cell acute lymphoblastic leukemias.
Blood 2005;106(13):4414-5.
-
2005: Kardos G; Zwaan C M; Kaspers G J L; de-Graaf S S N; de Bont E S J M; Postma A; Bökkerink J P M; Weening R S; van der Does-van den Berg A; van Wering E R; Korbijn C; Hählen K
Treatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trials.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(12):2063-71.
-
2005: Meier M; den Boer M L; Hall A G; Irving J A E; Passier M; Minto L; van Wering E R; Janka-Schaub G E; Pieters R
Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(11):1887-95.
-
2005: Brouwer Connie; Vogels-Mentink Trude M; Keizer-Garritsen Jenneke J; Trijbels Frans J M; Bökkerink Jos P M; Hoogerbrugge Peter M; van Wering Elisabeth R; Veerman Anjo J P; De Abreu Ronney A
Role of 5'-nucleotidase in thiopurine metabolism: enzyme kinetic profile and association with thio-GMP levels in patients with acute lymphoblastic leukemia during 6-mercaptopurine treatment.
Clinica chimica acta; international journal of clinical chemistry 2005;361(1-2):95-103.
-
2005: Pession Andrea; Valsecchi Maria Grazia; Masera Giuseppe; Kamps Willem A; Magyarosy Edina; Rizzari Carmelo; van Wering Elisabeth R; Lo Nigro Luca; van der Does Anna; Locatelli Franco; Basso Giuseppe; Aricò Maurizio
Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7161-7.
-
2005: van der Sluijs-Gelling A J; van der Velden V H J; Roeffen E T J M; Veerman A J P; van Wering E R
Immunophenotypic modulation in childhood precursor-B-ALL can be mimicked in vitro and is related to the induction of cell death.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(10):1845-7.
-
2005: van der Sluijs-Gelling A J; van der Velden V H J; Roeffen E T J M; Veerman A J P; van Wering E R
Reply to Gaipa et Al.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(10):1858.
-
2005: Tissing Wim J E; Meijerink Jules P P; den Boer Monique L; Brinkhof Bas; van Rossum Elisabeth F C; van Wering Elisabeth R; Koper Jan W; Sonneveld Pieter; Pieters Rob
Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):6050-6.
-
2005: Kaspers Gertjan J L; Wijnands Jelle J M; Hartmann Reinhard; Huismans Loekie; Loonen Anne H; Stackelberg Arend; Henze Guenter; Pieters Robrecht; Hählen Karel; Van Wering Elisabeth R; Veerman Anjo J P
Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia.
European journal of cancer (Oxford, England : 1990) 2005;41(9):1300-3.
-
2005: Stams Wendy A G; den Boer Monique L; Holleman Amy; Appel Inge M; Beverloo H Berna; van Wering Elisabeth R; Janka-Schaub Gritta E; Evans William E; Pieters Rob
Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia.
Blood 2005;105(11):4223-5.
-
2005: Stams Wendy A G; den Boer Monique L; Beverloo H Berna; Meijerink Jules P P; van Wering Elisabeth R; Janka-Schaub Gritta E; Pieters Rob
Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(8):2974-80.
-
2005: Brouwer Connie; De Abreu Ronney A; Keizer-Garritsen Jenneke J; Lambooy Lambert H J; Ament Kai; ter Riet Patricia G J H; van Wering Elisabeth R; Trijbels Frans J M; Veerman Anjo J P; Hoogerbrugge Peter M; Bökkerink Jos P M
Thiopurine methyltransferase in acute lymphoblastic leukaemia: biochemical and molecular biological aspects.
European journal of cancer (Oxford, England : 1990) 2005;41(4):613-23.
-
2005: Stams W A G; den Boer M L; Beverloo H B; van Wering E R; Pieters R
Upregulation of asparagine synthetase and cell cycle arrest in t(12;21)-positive ALL.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(2):318-9; author reply 319-21.
-
2004: van der Velden V H J; Brüggemann M; Hoogeveen P G; de Bie M; Hart P G; Raff T; Pfeifer H; Lüschen S; Szczepanski T; van Wering E R; Kneba M; van Dongen J J M
TCRB gene rearrangements in childhood and adult precursor-B-ALL: frequency, applicability as MRD-PCR target, and stability between diagnosis and relapse.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(12):1971-80.
-
2004: Hubeek I; Peters G J; Broekhuizen A J F; Talianidis I; Schouten van Meeteren A Y N; van Wering E R; Gibson B; Creutzig U; Kaspers G J L
Immunocytochemical detection of deoxycytidine kinase in pediatric malignancies in relation to in vitro cytarabine sensitivity.
Nucleosides, nucleotides & nucleic acids 2004;23(8-9):1351-6.
-
2004: van Wering E R; van Lochem E G; Leenders M; van der Sluijs-Gelling A J; Wind H; Gratama J W; Kraan J; Preijers F W M B
Three-color flowcytometric analysis of mature and immature hematological malignancies. A guideline of the Dutch Foundation for Immunophenotyping of Hematological Malignancies (SIHON).
Journal of biological regulators and homeostatic agents 2004;18(3-4):313-26.
-
2004: Dolman Koert M; Révész Thomas; Niemeyer Charlotte M; van Wering Elisabeth R; de Saint Basile Genevieve; Canninga Marijke; Bierings Marc B; Wulffraat Nico M
Myelodysplastic features in Griscelli syndrome.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2004;26(5):275-6.
-
2004: Szczepanski Tomasz; van der Velden Vincent H J; Hoogeveen Patricia G; de Bie Maaike; Jacobs Daniëlle C H; van Wering Elisabeth R; van Dongen Jacques J M
Vdelta2-Jalpha rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but rare in normal lymphoid cells.
Blood 2004;103(10):3798-804.
-
2004: van der Velden V H J; Boeckx N; van Wering E R; van Dongen J J M
Detection of minimal residual disease in acute leukemia.
Journal of biological regulators and homeostatic agents 2004;18(2):146-54.
-
2004: Szczepanski Tomasz; de Vaan Gerard A M; Beishuizen Auke; Bogman José; Jansen Mieke W J C; van Wering Elisabeth R; van Dongen Jacques J M
Acute lymphoblastic leukemia followed by a clonally-unrelated EBV-positive non-Hodgkin lymphoma and a clonally-related myelomonocytic leukemia cutis.
Pediatric blood & cancer 2004;42(4):343-9.
-
2004: Brüggemann M; van der Velden V H J; Raff T; Droese J; Ritgen M; Pott C; Wijkhuijs A J; Gökbuget N; Hoelzer D; van Wering E R; van Dongen J J M; Kneba M
Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(4):709-19.
-
2004: Annels Nicola E; Willemze Annemieke J; van der Velden Vincent H J; Faaij Claudia M J M; van Wering Elisabeth; Sie-Go Daisy M D S; Egeler R Maarten; van Tol Maarten J D; Révész Tom
Possible link between unique chemokine and homing receptor expression at diagnosis and relapse location in a patient with childhood T-ALL.
Blood 2004;103(7):2806-8.
-
2004: Ramakers-van Woerden N L; Beverloo H B; Veerman A J P; Camitta B M; Loonen A H; van Wering E R; Slater R M; Harbott J; den Boer M L; Ludwig W D; Haas O A; Janka-Schaub G E; Pieters R
In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(3):521-9.
-
2003: Szczepanski T; van der Velden V H J; Raff T; Jacobs D C H; van Wering E R; Brüggemann M; Kneba M; van Dongen J J M
Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of second T-ALL.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(11):2149-56.
-
2003: van der Velden V H J; Szczepanski T; Wijkhuijs J M; Hart P G; Hoogeveen P G; Hop W C J; van Wering E R; van Dongen J J M
Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual disease.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(9):1834-44.
-
2003: Den Boer M L; Harms D O; Pieters R; Kazemier K M; Gobel U; Körholz D; Graubner U; Haas R J; Jorch N; Spaar H J; Kaspers G J L; Kamps W A; Van der Does-Van den Berg A; Van Wering E R; Veerman A J P; Janka-Schaub G E
Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(17):3262-8.
-
2003: Kardos Gabriela; Baumann Irith; Passmore S Jane; Locatelli Franco; Hasle Henrik; Schultz Kirk R; Starý Jan; Schmitt-Graeff Annette; Fischer Alexandra; Harbott Jochen; Chessells Judith M; Hann Ian; Fenu Susanna; Rajnoldi Angelo Cantú; Kerndrup Gitte; Van Wering Elisabeth; Rogge Tim; Nollke Peter; Niemeyer Charlotte M
Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7.
Blood 2003;102(6):1997-2003.
-
2003: Zwaan Christian M; Reinhardt Dirk; Corbacioglu Selim; van Wering Elisabeth R; Bökkerink Jos P M; Tissing Wim J E; Samuelsson Ulf; Feingold Jay; Creutzig Ursula; Kaspers Gertjan J L
Gemtuzumab ozogamicin: first clinical experiences in children with relapsed/refractory acute myeloid leukemia treated on compassionate-use basis.
Blood 2003;101(10):3868-71.
-
2003: Stams Wendy A G; den Boer Monique L; Beverloo H Berna; Meijerink Jules P P; Stigter Rolinda L; van Wering Elisabeth R; Janka-Schaub Gritta E; Slater Rosalyn; Pieters Rob
Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL.
Blood 2003;101(7):2743-7.
-
2003: Kaaijk P; Kaspers G J L; Van Wering E R; Broekema G J; Loonen A H; Hählen K; Schmiegelow K; Janka-Schaub G E; Henze G; Creutzig U; Veerman A J P
Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia.
British journal of cancer 2003;88(5):775-81.
-
2002: von Bergh Anne R M; Beverloo H Berna; Rombout Paul; van Wering Elisabeth R; van Weel Margreet H; Beverstock Geoffrey C; Kluin Philip M; Slater Rosalyn M; Schuuring Ed
LAF4, an AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia.
Genes, chromosomes & cancer 2002;35(1):92-6.
-
2002: De Haas V; Kaspers G J L; Oosten L; Bresters D; Pieters R; Van Der Velden V H J; Van Wering E R; Van Den Berg H; Van Der Schoot C E
Is there a relationship between in vitro drug resistance and level of minimal residual disease as detected by polymerase chain reaction at the end of induction therapy in childhood acute lymphoblastic leukaemia?
British journal of haematology 2002;118(4):1190-1.
-
2002: van der Burg M; Barendregt B H; Szczepañski T; van Wering E R; Langerak A W; van Dongen J J M
Immunoglobulin light chain gene rearrangements display hierarchy in absence of selection for functionality in precursor-B-ALL.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(8):1448-53.
-
2002: van der Velden V H J; Jacobs D C H; Wijkhuijs A J M; Comans-Bitter W M; Willemse M J; Hählen K; Kamps W A; van Wering E R; van Dongen J J M
Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(8):1432-6.
-
2002: van der Velden V H J; Wijkhuijs J M; Jacobs D C H; van Wering E R; van Dongen J J M
T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(7):1372-80.
-
2002: Kamps W A; Bökkerink J P M; Hakvoort-Cammel F G A J; Veerman A J P; Weening R S; van Wering E R; van Weerden J F; Hermans J; Slater R; van den Berg E; Kroes W G; van der Does-van den Berg A
BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(6):1099-111.
-
2002: Bresters Dorine; Reus Angelino C W; Veerman Anjo J P; van Wering Elizabeth R; van der Does-van den Berg Anna; Kaspers Gertjan J L
Congenital leukaemia: the Dutch experience and review of the literature.
British journal of haematology 2002;117(3):513-24.
-
2002: Ramakers-van Woerden N L; Pieters R; Hoelzer D; Slater R M; den Boer M L; Loonen A H; Harbott J; Janka-Schaub G E; Ludwig W-D; Ossenkoppele G J; van Wering E R; Veerman A J P;
In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups.
Medical and pediatric oncology 2002;38(6):379-86.
-
2002: Ramakers-van Woerden N L; Pieters R; Rots M G; van Zantwijk C H; Noordhuis P; Beverloo H B; Peters G J; van Wering E R; Camitta B M; Pui C-H; Relling M V; Evans W E; Veerman A J P
Infants with acute lymphoblastic leukemia: no evidence for high methotrexate resistance.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(5):949-51.
-
2002: van der Velden V H J; Willemse M J; van der Schoot C E; Hählen K; van Wering E R; van Dongen J J M
Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(5):928-36.
-
2002: Szczepanski Tomasz; Willemse Marja J; Brinkhof Bas; van Wering Elisabeth R; van der Burg Mirjam; van Dongen Jacques J M
Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at relapse of childhood precursor-B-ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease.
Blood 2002;99(7):2315-23.
-
2002: de Haas V; Breunis W B; Dee R; Verhagen O J H M; Kroes W; van Wering E R; van Dongen J J M; van den Berg H; van der Schoot C E
The TEL-AML1 real-time quantitative polymerase chain reaction (PCR) might replace the antigen receptor-based genomic PCR in clinical minimal residual disease studies in children with acute lymphoblastic leukaemia.
British journal of haematology 2002;116(1):87-93.
-
2001: van der Velden V H; Joosten S A; Willemse M J; van Wering E R; Lankester A W; van Dongen J J; Hoogerbrugge P M
Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(9):1485-7.
-
2001: Szczepanski T; Willemse M J; van Wering E R; van Weerden J F; Kamps W A; van Dongen J J
Precursor-B-ALL with D(H)-J(H) gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(9):1415-23.
-
2001: van Wering E R; van der Linden-Schrever B E; van der Velden V H; Szczepanski T; van Dongen J J
T-lymphocytes in bone marrow samples of children with acute lymphoblastic leukemia during and after chemotherapy might hamper PCR-based minimal residual disease studies.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(8):1301-3.
-
2001: Lucio P; Gaipa G; van Lochem E G; van Wering E R; Porwit-MacDonald A; Faria T; Bjorklund E; Biondi A; van den Beemd M W; Baars E; Vidriales B; Parreira A; van Dongen J J; San Miguel J F; Orfao A;
BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(8):1185-92.
-
2001: van der Burg M; Barendregt B H; van Wering E R; Langerak A W; Szczepanski T; van Dongen J J
The presence of somatic mutations in immunoglobulin genes of B cell acute lymphoblastic leukemia (ALL-L3) supports assignment as Burkitt's leukemia-lymphoma rather than B-lineage ALL.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(7):1141-3.
-
2001: Beverloo H B; Panagopoulos I; Isaksson M; van Wering E; van Drunen E; de Klein A; Johansson B; Slater R
Fusion of the homeobox gene HLXB9 and the ETV6 gene in infant acute myeloid leukemias with the t(7;12)(q36;p13).
Cancer research 2001;61(14):5374-7.
-
2001: Slater R M; von Drunen E; Kroes W G; Weghuis D O; van den Berg E; Smit E M; van der Does-van den Berg A; van Wering E; Hählen K; Carroll A J; Raimondi S C; Beverloo H B
t(7;12)(q36;p13) and t(7;12)(q32;p13)--translocations involving ETV6 in children 18 months of age or younger with myeloid disorders.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(6):915-20.
-
2001: Bierings M; Szczepanski T; van Wering E R; Willemse M J; Langerak A W; Révész T; van Dongen J J
Two consecutive immunophenotypic switches in a child with immunogenotypically stable acute leukaemia.
British journal of haematology 2001;113(3):757-62.
-
2001: Hubeek I; Ramakers-van Woerden N L; Pieters R; Slater R; Beverloo H B; van Wering E R; Kamps W; Hählen K; Veerman A J
TEL/AML1 fusion is not a prognostic factor in Dutch childhood acute lymphoblastic leukaemia.
British journal of haematology 2001;113(1):254-5.
-
2001: Rots M G; Pieters R; Jansen G; Kaspers G J; Van Zantwijk C H; Noordhuis P; Voorn D A; Van Wering E R; Creutzig U; Veerman A J; Peters G J
A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemia.
European journal of cancer (Oxford, England : 1990) 2001;37(4):492-8.
-
2001: Ramakers-van Woerden N L; Pieters R; Slater R M; Loonen A H; Beverloo H B; van Drunen E; Heyman M; Moreno T C; Rots M G; van Wering E R; Kamps W A; Janka-Schaub G E; Veerman A J
In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemia.
British journal of haematology 2001;112(3):680-90.
-
2001: Szczepanski T; Willemse M J; Kamps W A; van Wering E R; Langerak A W; van Dongen J J
Molecular discrimination between relapsed and secondary acute lymphoblastic leukemia: proposal for an easy strategy.
Medical and pediatric oncology 2001;36(3):352-8.
-
2001: Kluin-Nelemans J; Van Wering E; Van Der Schoot C; Adriaansen H; Van'T Veer M; Van Dongen J; Gratama J;
SIHONSCORE: a scoring system for external quality control of leukaemia/lymphoma immunophenotyping measuring all analytical phases of laboratory performance.
British journal of haematology 2001;112(2):337-43.
-
2001: Bisschop M M; Révész T; Bierings M; van Weerden J F; van Wering E R; Hählen K; van der Does-van den Berg A
Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(1):46-9.
-
2000: Kamps W A; Veerman A J; van Wering E R; van Weerden J F; Slater R; van der Does-van den Berg A
Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984-1991.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(12):2240-6.
-
2000: Zwaan C M; Kaspers G J; Pieters R; Ramakers-Van Woerden N L; den Boer M L; Wünsche R; Rottier M M; Hählen K; van Wering E R; Janka-Schaub G E; Creutzig U; Veerman A J
Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia.
Blood 2000;96(8):2879-86.
-
2000: Verhagen O J; Willemse M J; Breunis W B; Wijkhuijs A J; Jacobs D C; Joosten S A; van Wering E R; van Dongen J J; van der Schoot C E
Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(8):1426-35.
-
2000: Ramakers-van Woerden N L; Pieters R; Loonen A H; Hubeek I; van Drunen E; Beverloo H B; Slater R M; Harbott J; Seyfarth J; van Wering E R; Hählen K; Schmiegelow K; Janka-Schaub G E; Veerman A J
TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.
Blood 2000;96(3):1094-9.
-
2000: van Wering E R; van der Linden-Schrever B E; Szczepanski T; Willemse M J; Baars E A; van Wijngaarde-Schmitz H M; Kamps W A; van Dongen J J
Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease.
British journal of haematology 2000;110(1):139-46.
-
2000: Szczepanski T; Langerak A W; Willemse M J; Wolvers-Tettero I L; van Wering E R; van Dongen J J
T cell receptor gamma (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia refelct 'end-stage' recombinations: implications for minimal residual disease monitoring.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(7):1208-14.
-
2000: Porwit-MacDonald A; Björklund E; Lucio P; van Lochem E G; Mazur J; Parreira A; van den Beemd M W; van Wering E R; Baars E; Gaipa G; Biondi A; Ciudad J; van Dongen J J; San Miguel J F; Orfao A
BIOMED-1 concerted action report: flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(5):816-25.
-
2000: Brouwer C; Keizer-Garritsen J J; Lambooy L H; Ament K; Ter Riet P G; De Abreu R A; Bökkerink J P; Van Wering E R; Van Der Does-Van Den Berg A; Veerman A J; Trijbels J P
Thiopurine methyl transferase: activity and genotyping in patients with acute lymphoblastic leukemia.
Advances in experimental medicine and biology 2000;486():327-31.
-
1999: Verhagen O J; Wijkhuijs A J; van der Sluijs-Gelling A J; Szczepanski T; van der Linden-Schrever B E; Pongers-Willemse M J; van Wering E R; van Dongen J J; van der Schoot C E
Suitable DNA isolation method for the detection of minimal residual disease by PCR techniques.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(8):1298-9.
-
1999: Kamps W A; Bökkerink J P; Hählen K; Hermans J; Riehm H; Gadner H; Schrappe M; Slater R; van den Berg-de Ruiter E; Smets L A; de Vaan G A; Weening R S; van Weerden J F; van Wering E R; den der Does-van den Berg A
Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991).
Blood 1999;94(4):1226-36.
-
1999: Szczepanski T; Pongers-Willemse M J; Langerak A W; Harts W A; Wijkhuijs A J; van Wering E R; van Dongen J J
Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage.
Blood 1999;93(12):4079-85.
-
1999: Lúcio P; Parreira A; van den Beemd M W; van Lochem E G; van Wering E R; Baars E; Porwit-MacDonald A; Bjorklund E; Gaipa G; Biondi A; Orfao A; Janossy G; van Dongen J J; San Miguel J F
Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(3):419-27.
-
1999: Hasle H; Aricò M; Basso G; Biondi A; Cantù Rajnoldi A; Creutzig U; Fenu S; Fonatsch C; Haas O A; Harbott J; Kardos G; Kerndrup G; Mann G; Niemeyer C M; Ptoszkova H; Ritter J; Slater R; Starý J; Stollmann-Gibbels B; Testi A M; van Wering E R; Zimmermann M
Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(3):376-85.
-
1999: Langerak A W; Wolvers-Tettero I L; van den Beemd M W; van Wering E R; Ludwig W D; Hählen K; Necker A; van Dongen J J
Immunophenotypic and immunogenotypic characteristics of TCRgammadelta+ T cell acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(2):206-14.
-
1999: Szczepanski T; Beishuizen A; Pongers-Willemse M J; Hählen K; Van Wering E R; Wijkhuijs A J; Tibbe G J; De Bruijn M A; Van Dongen J J
Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(2):196-205.
-
1998: van Dongen J J; Seriu T; Panzer-Grümayer E R; Biondi A; Pongers-Willemse M J; Corral L; Stolz F; Schrappe M; Masera G; Kamps W A; Gadner H; van Wering E R; Ludwig W D; Basso G; de Bruijn M A; Cazzaniga G; Hettinger K; van der Does-van den Berg A; Hop W C; Riehm H; Bartram C R
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.
Lancet 1998;352(9142):1731-8.
-
1998: Pieters R; den Boer M L; Durian M; Janka G; Schmiegelow K; Kaspers G J; van Wering E R; Veerman A J
Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(9):1344-8.
-
1998: Kaspers G J; Pieters R; Van Zantwijk C H; Van Wering E R; Van Der Does-Van Den Berg A; Veerman A J
Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs.
Blood 1998;92(1):259-66.
-
1997: Beishuizen A; de Bruijn M A; Pongers-Willemse M J; Verhoeven M A; van Wering E R; Hählen K; Breit T M; de Bruin-Versteeg S; Hooijkaas H; van Dongen J J
Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11(12):2200-7.
-
1997: Kaspers G J; Veerman A J; Pieters R; Van Zantwijk C H; Smets L A; Van Wering E R; Van Der Does-Van Den Berg A
In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia.
Blood 1997;90(7):2723-9.
-
1997: Niemeyer C M; Arico M; Basso G; Biondi A; Cantu Rajnoldi A; Creutzig U; Haas O; Harbott J; Hasle H; Kerndrup G; Locatelli F; Mann G; Stollmann-Gibbels B; van't Veer-Korthof E T; van Wering E; Zimmermann M
Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)
Blood 1997;89(10):3534-43.
-
1997: Vervoordeldonk S F; Merle P A; Behrendt H; Steenbergen E J; van den Berg H; van Wering E R; von dem Borne A E; van der Schoot C E; van Leeuwen E F; Slaper-Cortenbach I C
PCR-positivity in harvested bone marrow predicts relapse after transplantation with autologous purged bone marrow in children in second remission of precursor B-cell acute leukaemia.
British journal of haematology 1997;96(2):395-402.
-
1997: Verschuren M C; Wolvers-Tettero I L; Breit T M; Noordzij J; van Wering E R; van Dongen J J
Preferential rearrangements of the T cell receptor-delta-deleting elements in human T cells.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(3):1208-16.
-
1996: Kluin-Nelemans J C; van Wering E R; van'T Veer M B; van der Schoot C E; Adriaansen H J; van der Burgh F J; Gratama J W
Pitfalls in the immunophenotyping of leukaemia and leukaemic lymphomas: survey of 9 years of quality control in The Netherlands. Dutch Cooperative Study Group on Immunophenotyping of Haematological Malignancies (SIHON).
British journal of haematology 1996;95(4):692-9.
-
1996: Kaspers G J; Veerman A J; Popp-Snijders C; Lomecky M; Van Zantwijk C H; Swinkels L M; Van Wering E R; Pieters R
Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.
Medical and pediatric oncology 1996;27(2):114-21.
-
1996: Kaspers G J; Veerman A J; Van Wering E R; Van Der Linden-Schrever B E; Van Zantwijk C H; Van Der Does-Van Den Berg A; Pieters R
Prognostic significance of peanut agglutinin binding in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(4):675-81.
-
1996: Veerman A J; Hählen K; Kamps W A; Van Leeuwen E F; De Vaan G A; Solbu G; Suciu S; Van Wering E R; Van der Does-Van der Berg A
High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(3):911-8.
-
1996: Coebergh J W; van der Does-van den Berg A; Hop W C; van Weerden F; Rammeloo J A; van Steensel H A; van Wering E R; Kamps W A
Small influence of parental educational level on the survival of children with leukaemia in The Netherlands between 1973 and 1979.
European journal of cancer (Oxford, England : 1990) 1996;32A(2):286-9.
-
1995: Smets L A; Slater R; van Wering E R; van der Does-van den Berg A; Hart A A; Veerman A J; Kamps W A
DNA index and %S-phase cells determined in acute lymphoblastic leukemia of children: a report from studies ALL V, ALL VI, and ALL VII (1979-1991) of the Dutch Childhood Leukemia Study Group and The Netherlands Workgroup on Cancer Genetics and Cytogenetics.
Medical and pediatric oncology 1995;25(6):437-44.
-
1995: Kaspers G J; Pieters R; Van Zantwijk C H; Van Wering E R; Veerman A J
Clinical and cell biological features related to cellular drug resistance of childhood acute lymphoblastic leukemia cells.
Leukemia & lymphoma 1995;19(5-6):407-16.
-
1995: Klumper E; Pieters R; Veerman A J; Huismans D R; Loonen A H; Hählen K; Kaspers G J; van Wering E R; Hartmann R; Henze G
In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia.
Blood 1995;86(10):3861-8.
-
1995: Klumper E; Pieters R; Kaspers G J; Huismans D R; Loonen A H; Rottier M M; van Wering E R; van der Does-van den Berg A; Hählen K; Creutzig U
In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(11):1864-9.
-
1995: Beverloo H B; Le Coniat M; Wijsman J; Lillington D M; Bernard O; de Klein A; van Wering E; Welborn J; Young B D; Hagemeijer A
Breakpoint heterogeneity in t(10;11) translocation in AML-M4/M5 resulting in fusion of AF10 and MLL is resolved by fluorescent in situ hybridization analysis.
Cancer research 1995;55(19):4220-4.
-
1995: Klumper E; Giaccone G; Pieters R; Broekema G; van Ark-Otte J; van Wering E R; Kaspers G J; Veerman A J
Topoisomerase II alpha gene expression in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(10):1653-60.
-
1995: van Wering E R; Beishuizen A; Roeffen E T; van der Linden-Schrever B E; Verhoeven M A; Hählen K; Hooijkaas H; van Dongen J J
Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(9):1523-33.
-
1995: Kaspers G J; Veerman A J; Pieters R; Van Zantwijk I; Hählen K; Van Wering E R
Drug combination testing in acute lymphoblastic leukemia using the MTT assay.
Leukemia research 1995;19(3):175-81.
-
1995: Kaspers G J; Smets L A; Pieters R; Van Zantwijk C H; Van Wering E R; Veerman A J
Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study.
Blood 1995;85(3):751-6.
-
1994: Kaspers G J; Kardos G; Pieters R; Van Zantwijk C H; Klumper E; Hählen K; de Waal F C; van Wering E R; Veerman A J
Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(7):1224-9.
-
1994: Beishuizen A; Verhoeven M A; van Wering E R; Hählen K; Hooijkaas H; van Dongen J J
Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis.
Blood 1994;83(8):2238-47.
-
1994: Pieters R; Kaspers G J; Klumper E; van Wering E R; van der Does-van den Berg A; Veerman A J
[Clinical relevance of resistance against cytostatic agents in children with leukemia]
Nederlands tijdschrift voor geneeskunde 1994;138(14):706-12.
-
1994: Kaspers G L; Veerman A J; Pieters R; van Zantwijk I; Klumper E; Hählen K; de Waal F C; van Wering E R
In vitro cytotoxicity of mitoxantrone, daunorubicin and doxorubicin in untreated childhood acute leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(1):24-9.
-
1993: Breit T M; Beishuizen A; Ludwig W D; Mol E J; Adriaansen H J; van Wering E R; van Dongen J J
tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(12):2004-11.
-
1993: Coebergh J W; van der Does-van den Berg A; Kamps W A; Rammeloo J A; van Steensel-Moll H A; van Wering E R
[The significance of cluster analysis in the study of causes of leukemia in children]
Nederlands tijdschrift voor geneeskunde 1993;137(45):2296-301.
-
1993: Breit T M; Wolvers-Tettero I L; Beishuizen A; Verhoeven M A; van Wering E R; van Dongen J J
Southern blot patterns, frequencies, and junctional diversity of T-cell receptor-delta gene rearrangements in acute lymphoblastic leukemia.
Blood 1993;82(10):3063-74.
-
1993: Beishuizen A; Verhoeven M A; Hählen K; van Wering E R; van Dongen J J
Differences in immunoglobulin heavy chain gene rearrangmeent patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leaukemia at diagnosis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(6):60-3.
-
1993: Breit T M; Mol E J; Wolvers-Tettero I L; Ludwig W D; van Wering E R; van Dongen J J
Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes.
The Journal of experimental medicine 1993;177(4):965-77.
-
1993: Pieters R; Kaspers G J; van Wering E R; Huismans D R; Loonen A H; Hählen K; Veerman A J
Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(3):392-7.
-
1993: van Wering E R; Brederoo P; van Staalduinen G J; van der Meulen J; van der Linden-Schrever B E; van Dongen J J
Contribution of electron microscopy to the classification of minimally differentiated acute leukemias in children.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;131():77-87.
-
1993: Pieters R; Kaspers G J; van Wering E R; Huismans D R; Loonen A H; Hählen K; Veerman A J
Cellular drug sensitivity of immunophenotypic subgroups of childhood acute lymphoblastic leukemia.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;131():249-56.
-
1992: Pieters R; Huismans D R; Loonen A H; Peters G J; Hählen K; van der Does-van den Berg A; van Wering E R; Veerman A J
Relation of 5'-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia.
Leukemia research 1992;16(9):873-80.
-
1992: Pieters R; Huismans D R; Loonen A H; Peters G J; Hählen K; van der Does-van den Berg A; van Wering E R; Veerman A J
Adenosine deaminase and purine nucleoside phosphorylase in childhood lymphoblastic leukemia: relation with differentiation stage, in vitro drug resistance and clinical prognosis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6(5):375-80.
-
1992: Pieters R; Huismans D R; Loonen A H; Peters G J; Hählen K; van der Does-van den Berg A; van Wering E R; Veerman A J
Hypoxanthine-guanine phosphoribosyl-transferase in childhood leukemia: relation with immunophenotype, in vitro drug resistance and clinical prognosis.
International journal of cancer. Journal international du cancer 1992;51(2):213-7.
-
1992: van't Veer M B; Kluin-Nelemans J C; van der Schoot C E; van Putten W L; Adriaansen H J; van Wering E R
Quality assessment of immunological marker analysis and the immunological diagnosis in leukaemia and lymphoma: a multi-centre study. Dutch Cooperative Study Group on Immunophenotyping of Leukaemias and Lymphomas (SIHON).
British journal of haematology 1992;80(4):458-65.
-
1992: Breit T M; Wolvers-Tettero L M; Hählen K; van Wering E R; van Dongen J J
Extensive junctional diversity of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemias: implications for the detection of minimal residual disease.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6(2):169-70.
-
1992: Haumann T J; van Wering E R; van der Does-van den Berg A; Pieters R; Huisjes A J; Veerman A J
Value of routine bone marrow examination for detection of bone marrow relapse in children with standard risk acute lymphoblastic leukemia.
Pediatric hematology and oncology 1992;9(1):41-7.
-
1991: Breit T M; Wolvers-Tettero I L; Hählen K; van Wering E R; van Dongen J J
Extensive junctional diversity of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemias: implications for the detection of minimal residual disease.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5(12):1076-86.
-
1991: Kaspers G J; Pieters R; Van Zantwijk C H; De Laat P A; De Waal F C; Van Wering E R; Veerman A J
In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood.
British journal of cancer 1991;64(3):469-74.
-
1991: Beishuizen A; Hählen K; Hagemeijer A; Verhoeven M A; Hooijkaas H; Adriaansen H J; Wolvers-Tettero I L; van Wering E R; van Dongen J J
Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukemia of precursor B-cell origin.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5(8):657-67.
-
1991: Pieters R; Huismans D R; Loonen A H; Hählen K; van der Does-van den Berg A; van Wering E R; Veerman A J
Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia.
Lancet 1991;338(8764):399-403.
-
1991: Breit T M; Wolvers-Tettero I L; Hählen K; van Wering E R; van Dongen J J
Limited combinatorial repertoire of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemias.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5(2):116-24.
-
1991: Coebergh J W; van der Does-van den Berg A; Kamps W A; Rammeloo J A; Valkenburg H A; van Wering E R
Malignant lymphomas in children in The Netherlands in the period 1973-1985: incidence in relation to leukemia: a report from the Dutch Childhood Leukemia Study Group.
Medical and pediatric oncology 1991;19(3):169-74.
-
1990: van Wering E R; Brederoo P; van Dijk-de Leeuw J H; van der Meulen J; van 't Veer M B
Electron microscopy: a contribution to further classification of acute unclassifiable childhood leukemia.
Blut 1990;60(5):291-6.
-
1990: Behrendt H; van Leeuwen E F; Schuwirth C; Verkes R J; Hermans J; van der Does-van den Berg A; van Wering E R
Bone marrow relapse occurring as first relapse in children with acute lymphoblastic leukemia.
Medical and pediatric oncology 1990;18(3):190-6.
-
1990: Slater R M; Smeets D F; Hagemeijer A; De Jong B; Beverstock C G; Geraedts J P; van der Does-van den Berg A; van Wering E R; Veerman A J
Update of the cytogenetic study of childhood non-high-risk acute lymphocytic leukemia at diagnosis in protocol VI of the Dutch Childhood Leukemia Study Group.
Haematology and blood transfusion 1990;33():169-73.
-
1989: Behrendt H; van Leeuwen E F; Schuwirth C; Verkes R J; Hermans J; van der Does-van den Berg A; van Wering E R
The significance of an isolated central nervous system relapse, occurring as first relapse in children with acute lymphoblastic leukemia.
Cancer 1989;63(10):2066-72.
-
1989: Coebergh J W; van der Does-van den Berg A; van Wering E R; van Steensel-Moll H A; Valkenburg H A; van't Veer M B; Schmitz P I; van Zanen G E
Childhood leukaemia in The Netherlands, 1973-1986: temporary variation of the incidence of acute lymphocytic leukaemia in young children.
British journal of cancer 1989;59(1):100-5.
-
1989: Van Noorden C J; Vogels I M; Van Wering E R
Enzyme cytochemistry of unfixed leukocytes and bone marrow cells using polyvinyl alcohol for the diagnosis of leukemia.
Histochemistry 1989;92(4):313-8.
-
1989: van der Does-van den Berg A; van Wering E R; Suciu S; Solbu G; van 't Veer M B; Rammeloo J A; de Koning J; van Zanen G E
Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
The American journal of pediatric hematology/oncology 1989;11(2):125-33.
-
1988: van Duijn C M; van Steensel-Moll H A; van der Does-vd Berg A; van Wering E R; van Zanen G E; Valkenburg H A; Rammeloo J A
Infant feeding and childhood cancer.
Lancet 1988;2(8614):796-7.
-
1988: Kamps W A; Sjamsoedin-Visser E J; van Wering E R
[The infant with leukemia]
Tijdschrift voor kindergeneeskunde 1988;56(2):99-104.
-
1988: van der Does-van den Berg A; van Wering E R; Suciu S; Solbu G; Rammeloo J A; de Koning J; van Zanen G E
[Results of treatment of children with acute lymphatic leukemia (ALL) according to the ALL V protocol of the Netherlands Working Group on Leukemia in Children]
Tijdschrift voor kindergeneeskunde 1988;56(2):61-6.
-
1988: Behrendt H; van Leeuwen E F; Schuwirth C; Verkes R J; Hermans J; van der Does-van den Berg A; van Wering E R
[Significance of recurrence in children with acute lymphatic leukemia]
Tijdschrift voor kindergeneeskunde 1988;56(2):67-72.
-
1988: van Wering E R; Veerman A J; van der Linden-Schrever B E
Diagnosis of meningeal involvement in childhood acute lymphoblastic leukemia: cytomorphology and TdT.
European journal of haematology 1988;40(3):250-5.
-
1988: van Dongen J J; Krissansen G W; Wolvers-Tettero I L; Comans-Bitter W M; Adriaansen H J; Hooijkaas H; van Wering E R; Terhorst C
Cytoplasmic expression of the CD3 antigen as a diagnostic marker for immature T-cell malignancies.
Blood 1988;71(3):603-12.
-
1987: van der Does-van den Berg A; van Wering E R; de Koning J; Rammeloo J A; Solbu G; Suciu S; van Zanen G E
Addition of rubidomycin to induction treatment with vincristine, prednisone, and L-asparaginase in standard-risk childhood acute lymphocytic leukemia (study ALL V): a report on behalf of the Dutch Childhood Leukemia Study Group.
Haematology and blood transfusion 1987;30():444-7.
-
1986: van Wering E R; van 't Veer M B; Akkerboom J C; Vissers-Praalder E C; Pinkster T; de Waal F C
[The significance of the leukocyte count and immunological typing for the prognosis of acute lymphatic leukemia in children]
Nederlands tijdschrift voor geneeskunde 1986;130(4):165-9.
-
1985: Coebergh J W; van Steensel-Moll H A; Van Wering E R; van't Veer M B
Epidemiological and immunological characteristics of childhood leukaemia in The Netherlands: population-based data from a nationwide co-operative group of paediatricians.
Leukemia research 1985;9(6):683-8.
-
1983: van der Reijden H J; van Wering E R; van de Rijn J M; Melief C J; van 't Veer M B; Behrendt H; von dem Borne A E
Immunological typing of acute lymphoblastic leukaemia.
Scandinavian journal of haematology 1983;30(4):356-66.
Sign-in to see more
